A team of Penn researchers are using the HIV virus to cure cancer.
The efforts of Penn Medicine’s Dr. Carl June and his team have been described as a “breakthrough treatment” for leukemia in the New York Times. June’s work is backed in part by a $3 million grant from Richard Vague, the investor who founded early stage investment firm Gabriel Investments and is a large supporter of Fringe Festival and other cultural efforts in the city.
Watch a video about June’s work below.-30-
3 ways the Pennovation Center helps its women entrepreneurs accomplish their goals
Blackfynn expands partnership with the Michael J. Fox Foundation
NeuroFlow wins pitch competition at HIMSS healthcare conference
Why Deacom’s team prioritizes collaboration and continuous improvement
Science Center just gave $700K to support four local researchers
Get access to 100 services on the new website for Philly’s health department
What does ‘digital transformation’ mean for healthcare startups in 2019?
Engineers have Vistar Media’s Philly office all to themselves
Sign-up for daily news updates from Technical.ly Philadelphia